Abstract
Shipments of a Chinese and Canadian-developed COVID-19 candidate vaccine remain delayed from getting to Canada, more than three months after Health Canada approved them for Phase 1 trials here.
| Original language | Canadian English |
|---|---|
| Publication status | Published - Jan. 1 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- COVID-19
- Vaccination Production
- Canada
Disciplines
- Food and Drug Law
- Health Law and Policy
- Law
- Law and Society
- Science and Technology Law
Fingerprint
Dive into the research topics of 'Potential COVID-19 Vaccine Still Not in Canada, Three Months After Approval for Trials'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver